Navigation Links
Personalized Stem Cells, Inc. Announces Clinical Trial Sites Qualified for FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells
Date:9/24/2019

Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, has completed training and site qualification for clinical trial sites and physician investigators. The clinical trial sites are now in the process of recruitment and screening of potential clinical trial participants.

Clinical trial sites are currently located in San Diego and Los Angeles California, Portland Oregon, and Chicago Illinois. Additional clinical trial sites are anticipated in Q4 2019 and early 2020.

In July of 2019, PSC received FDA approval for a New Drug (IND) application for use of a person’s own adipose-derived stem cells to treat their osteoarthritis in clinical trials. The first clinical trial will use stem cells to treat osteoarthritis in the knee. In just two months, PSC has recruited, trained, and qualified clinical trial sites sufficient to treat up to 125 patients in this first clinical trial

This is the first of several planned clinical trials which will enable qualified PSC-enrolled physicians to provide FDA compliant, quality cell therapy to patients suffering from osteoarthritis. PSC plans to conduct a series of FDA approved clinical trials starting with uses in orthopedics and expanding to other medical conditions in the future.

PSC is working within the FDA cell therapy regulations to provide stem cell therapy for patients that follows the rules FDA has created in order to assure consistent manufacturing, quality tested cells and clinical trial and manufacturing oversite for safety and efficacy.

PSC was founded by Robert Harman, DVM, MPVM and Michael Dale, both of whom also co-founded VetStem Biopharma and are both experienced serial entrepreneurs.

“We are fortunate to have thought leaders and experienced regenerative medicine physicians and support staff to launch our first clinical trial. We look forward to expanding the physician network as additional clinical trials are approved in the near future. The high demand for FDA approved stem cell therapy has created a terrific opportunity for visionary and highly skilled physicians to work with PSC and within FDA regulation.” says Mr. Dale.

PSC has enrolled a limited number of clinical sites around the U.S. to provide treatment of knee osteoarthritis using stem cells. The physicians in this first clinical trial are among the most experienced stem cell physicians in the country. Contact PSC for clinical trial information, clinical trial site locations, or investment information.

About Personalized Stem Cells, Inc.
Personalized Stem Cells was formed in 2018 to advance and legitimize human regenerative medicine. This privately held biopharmaceutical enterprise, based near San Diego (California), offers qualified physicians who enroll, an FDA compliant autologous stem cell product (from patient’s own fat tissue) for use in FDA approved clinical trials. PSC is driving development and adoption of stem cell and regenerative medicine within the FDA-IND process by providing cGMP manufactured, quality tested cells, and well-defined clinical trials. PSC has licensed a portfolio of over 70 issued patents in the field of regenerative medicine.

Read the full story at https://www.prweb.com/releases/personalized_stem_cells_inc_announces_clinical_trial_sites_qualified_for_fda_approved_clinical_trial_for_treatment_of_osteoarthritis_with_stem_cells/prweb16594643.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Personalized Stem Cells, Inc. Submits Investigational New Drug (IND) Application for the Treatment of Osteoarthritis with Stem Cells
2. VetStem Biopharma, Parent Company of Personalized Stem Cells, is Approved for Stem Cell Manufacturing by the California Department of Public Health
3. A New Kind of Thinking Cap: Worcester Polytechnic Institute Researchers Are Using Brain Imaging to Improve Personalized Learning Environments
4. RSNA: Personalized Treatment Benefits Kidney Cancer Patients
5. PhysIQ Personalized Physiology Analytics (PPA) Wins DPharm Idol 2017
6. Director of Scientific Programs of NIH’s All of Us Research Program to Provide Update at the 9th Annual Personalized & Precision Medicine Conference
7. ACEA Biosciences Announces Collaboration with Memorial Sloan Kettering Cancer Center on Personalized CAR T Cell Therapy
8. ISABS: Personalized Medicine Conference With Nobel Prize Laureates Participation to be Held in Dubrovnik, Croatia
9. Notable Labs Enters into a Collaboration Agreement with IntelliCyt to Develop a Phenotypic Personalized Medicine Platform for Cancer Patients
10. Proove Health Foundation Is Created to Support the Role of Personalized Medicine in Public Health Epidemics
11. IntelliCyt and FIMM Announce a Collaboration to Advance Personalized Medicine in Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/10/2020)... ... January 09, 2020 , ... ... announced its inaugural GenScript Biotech Global Forum on Jan. 14 in San Francisco, ... "Cell and Gene Therapy and the Booming China Market," will feature gene and ...
(Date:1/8/2020)... ... January 08, 2020 , ... RMA of Connecticut , ... grow their family, has announced that five of their Board-Certified reproductive endocrinologists have ... the renowned publishing company Castle Connolly has compiled the list of ...
(Date:1/7/2020)... (PRWEB) , ... January 07, 2020 , ... Vuja De ... cancer progression and recurrence, today announced the appointments of Chand Khanna, DVM, PhD, DACVIM ... and CEO of Vuja De said, “We are delighted to welcome Chand and Lee ...
(Date:1/7/2020)... (PRWEB) , ... January 06, 2020 , ... ... Control, today announced its expansion into whole-home smart lighting with two new products: ... Switch unlocks the ability for homeowners and homebuilders to affordably add high-end smart ...
Breaking Biology Technology:
(Date:1/23/2020)... ATLANTA (PRWEB) , ... January 23, 2020 , ... ... to manufacture lifesaving mature red blood cells from stem cells. The red ... red blood cells, under strictly controlled conditions, for transfusion therapy and replaces the ...
(Date:1/22/2020)... ... January 21, 2020 , ... Astro Pak’s president ... Business Development Department. The move, which is part of the company’s structural reorganization, ... the company’s Senior Vice President where he oversaw its Cleanroom Division as well ...
(Date:1/22/2020)... (PRWEB) , ... January 21, ... ... specializes in integrating cold chain operations, developing transport validation strategies, supporting global ... by both Inc. 5000 and the Houston Business Journal as a fastest ...
Breaking Biology News(10 mins):